NIHR Local Clinical Research Network Funding Allocations 2019/20
Purpose of this document
This document provides information on the NIHR Local Clinical Research Network (LCRN) funding allocations for the 2019/20 financial year (see Table 2).
Purpose of CRN funding model
The purpose of the CRN funding model is to best apportion the national CRN funding allocation from the Department of Health and Social Care (DHSC) to the 15 LCRNs in pursuance of the aims of the NIHR CRN as set out in the NIHR Briefing Note for the CRN, and the CRN High Level Objectives. For the 2019/20 financial year, the CRN funding model has been radically simplified and the basis will remain unchanged for a minimum three-year period.
Overview of CRN funding model 2019/20
The CRN funding model for 2019/20 has two components: ‘Core’ and ‘Topsliced’.
- The core component is a two-part model consisting of a fixed and a variable element.
- Fixed element - 80% of core funding, using the 2018/19 allocations as the baseline for the calculations, and allowing LCRNs to plan effectively.
- Variable element - 20% of core funding, used to incentivise and reward LCRNs in pursuance of DHSC strategic initiatives and objectives. The factors determining the distribution of this element - i.e. the allocation of this element - could by definition be changed year on year. Further information on the variable element is provided below.
- The ‘top-sliced’ component provides for national NHS service support functions and CRN National Specialty Leads. This has been deducted from the total CRN allocation prior to the core fixed and variable elements being calculated.
In addition, DHSC will provide separate funding to LCRN Host Organisations for the provision of services related to Excess Treatment Costs. Core funding component - Variable element Funding allocations within the variable element were calculated using performance data in relation to CRN High Level Objectives (HLOs) 1, 2a and 2b, and CRN Specialty Objectives. Each of these four factors determined 5% of the total core funding allocation, i.e. 20% of core funding in total.
The data for Specialty Objectives include all 2017/18 objectives with the exception of:
o Dementias and neurodegeneration, Cardiovascular Disease, Gastroenterology, and Infection, as these have national objectives
o Oral and Dental health, due to an incomplete data set
o Ophthalmology, as the data were not usable for this purpose.
A balanced scorecard approach was used to calculate the allocation for each LCRN. This ensured that all LCRNs received some funding from the variable element. The methodology was to apply a score to the 2017/18 HLO and Specialty objectives outturn data at an LCRN level; the better the performance, the higher the score awarded. An example, using HLO 1, is provided in Table 1 below:
|% of Target Achieved (Success Rate)||Point Awarded|
Table 1: Points awarded in the balanced scorecard based on HLO1 target achieved.
To ensure the volume and complexities of the HLOs were taken into account, the scores per LCRN for HLO 1 were multiplied by the number of participants recruited, and the scores for HLO 2a and HLO 2b were multiplied by the number of studies that achieved the recruitment to time and target aim of 80%.
Host Corporate Support Services
LCRNs are provided with an allowable expenditure to provide a range of corporate support facilities and services that facilitate the governance, leadership and management of the LCRN. These services typically include: financial management and reporting; human resources; information technology and governance; office space, facilities and equipment; legal and contracting support.
Cap and Collar
The funding model aims to avoid major fluctuations in year on year funding, thus providing stability in the NIHR infrastructure and allow LCRNs to plan more effectively.
As in previous years, a +/- 5% Cap and Collar has been applied to the 2019/20 CRN funding model. The top-sliced element and Excess Treatments Costs are excluded from this calculation.
Conducting research in populations with the most need
LCRNs are requested to ring-fence 2% of the 2019/20 allocation to support initiatives to improve the correlation between local population health needs and LCRN research portfolio activity.
Any enquiries regarding the 2019/20 LCRN funding allocations should be emailed to Sally Johnson, LCRN Funding and Contracts Manager, via firstname.lastname@example.org.
Table 2: Final LCRN funding allocations 2019/20
|LCRN||Fixed funding element1 £||Variable Element2 £||Total pre-top sliced £||Top-sliced £||ETC Service Funding £||Final allocation £|
|Kent, Surrey and Sussex||11,297,656||2,779,394||14,077,050||0||58,000||14,135,050|
|North East and North Cumbria||14,328,680||3,796,411||18,125,091||48,701||78,000||18,251,792|
|North West Coast||12,861,884||3,023,738||15,885,622||80,263||49,000||16,014,885|
|North West London||11,053,785||3,458,837||14,512,622||42,742||87,000||14,642,364|
|South West Peninsula||8,501,859||2,479,550||10,981,408||65,701||41,000||11,088,109|
|Thames Valley and South Midlands||12,134,992||3,234,887||15,369,879||36,040||85,000||15,490,919|
|West of England||10,043,354||2,470,607||12,513,961||13,500||66,000||12,593,461|
|Yorkshire and Humber||20,854,428||4,999,593||25,854,021||281,555||89,000||26,224,576|
1 - With LCRN adjustments included
2 - With Cap and Collar adjustment included